Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
HHS
HHS Claims Lower Drug Prices Following “American Patients First” Blueprint
On May 11, 2018, the White House announced its American Patients First Blueprint aimed at reducing drug prices. Following the…
Is HHS Committed to Lowering Drug Prices?
On Tuesday, June 12, 2018, United States Health and Human Services (HHS) Secretary Alex Azar appeared before the United States…
Senate Confirmation Hearing for Alex Azar – Open Payments to Remain…
On January 9, 2018, the Senate Finance Committee held a nomination hearing for Alex Azar, President Trump’s pick to lead the…
HHS OIG Releases Report on Potential Drug Misclassifications
A report recently released by the Department of Health and Human Services (HHS) Office of Inspector General (OIG) found that…
Trump Nominates Alex Azar to Head HHS
A few weeks ago, President Donald Trump nominated Alex Azar to lead the Department of Health and Human Services (HHS), following…
United States Senate Focuses on Opioids
Senate Finance Committee Chairman Orrin Hatch, along with 10 of his Republican Committee colleagues, recently called on the…
Prices Testifies On Proposed Budget Cuts
We continue to follow the President’s budgets with potential cuts to the NIH and possible legislation to address drug prices. With…
Medicare Backlog Must Be Fixed
Since 2014, the American Hospital Association (AHA) has been in court with HHS regarding HHS’ failure to meet statutorily-imposed…
Tom Price on MACRA and Value-Based Care
During the last weeks of the Obama Administration, CMS continued to roll out new mandatory bundled payments models. Rep. Tom Price…
Senate Finance Committee Holds Hearing on Dr. Price to Lead Department of…
On Tuesday, January 24, 2017, the Senate Committee on Finance held a hearing to consider the nomination of Representative Thomas…